4
Changes in Ownership
MBX Biosciences, Inc. Filed Acc 0001193125-26-082562
President & CEO acquired 28,768 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Hawryluk P. Kent · President & CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-26 | Exercise or conversion : show line 1 in the form | +28,768 | $16.00 | $460,288 | 728,274 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-26 | Exercise or conversion : show line 2 in the form Stock option (right to buy) | −28,768 | 91,668 | D |
Loading xslF345X05/ownership.xml…